Post Subject #550   0 THE BUYOUT RUMORS ARE SWIRLING ... GO ICPT jr5555 06/15/18 11:20:14 AM #549   0 THE BUYOUT RUMORS ARE SWIRLING ... GO ICPT jr5555 06/15/18 11:20:12 AM #548   0 Is this coming alive again? Sold out of harry crumb 04/16/18 03:31:10 PM #547   0 Looks like the 8K came out late Friday. Zilla 02/18/18 10:05:01 AM #546   0 ICPT’s partner dumps Ocaliva for Japanese/Korean markets; this DewDiligence 02/14/18 08:23:29 AM #545   0 Please see the posts linked in #msg-137643821 and DewDiligence 01/23/18 10:42:47 AM #544   0 The article somewhat overstates the PBC safety issues, abcd12 01/23/18 09:15:26 AM #543   0 The article somewhat overstates the PBC safety issues, DewDiligence 01/12/18 11:44:30 AM #542   0 I like to see opposing view points from abcd12 01/12/18 11:01:31 AM #541   0 JPM just recently filed 13G. abcd12 01/11/18 09:34:28 AM #540   0 ICPT ... It must be very painful no osaffer 01/09/18 02:26:54 AM #539   0 On Watch For Breakout In Shares Of Intercept ITMS 12/20/17 03:06:53 PM #538   0 Ocaliva > < Elafibranor osaffer 12/19/17 09:27:54 AM #537   0 Recent changes to REGENERATE trial: DewDiligence 11/27/17 01:32:07 PM #536   0 ICPT hires R&D head: DewDiligence 11/27/17 11:56:38 AM #535   0 Rachel McMinn is leaving the company effective 12/31/17. DewDiligence 11/01/17 03:28:43 PM #534   0 ICPT stopped development of INT-767, the backup FXR DewDiligence 11/01/17 03:28:15 PM #533   0 ICPT 3Q17 PR: DewDiligence 11/01/17 03:28:01 PM #532   0 ICPT 3Q17 CC slides: DewDiligence 11/01/17 02:33:10 PM #531   0 Probably needs a couple days... fireopal 09/25/17 07:02:42 PM #530   0 Intercept Pharmaceuticals (ICPT) Worst-Case is 'Surmountable', No Change fireopal 09/25/17 07:01:48 PM #529   0 ICPT attempt at damage control fails to lift DewDiligence 09/25/17 03:00:13 PM #526   0 We cannot be happy when at least 26 osaffer 09/21/17 06:18:54 PM #525   0 Well osaffer you got your wish I hope Spike5 09/21/17 11:50:04 AM #524   0 https://seekingalpha.com/article/4107001-intercepts-fall-creates-monumental-buyi Inoviorulez 09/15/17 01:32:56 AM #523   0 Not good for ICPT osaffer 09/13/17 08:13:12 AM #522   0 OCA seems to be not so yummy osaffer 09/12/17 09:43:40 AM #521   0 https://goo.gl/TbBfGV OCA Game Over osaffer 09/12/17 09:38:25 AM #520   0 ICPT –16% on Ocaliva safety warning: #msg-134545079. DewDiligence 09/12/17 09:31:52 AM #519   0 :-) osaffer 08/03/17 10:52:01 AM #518   0 That blogger is as bearish on ICPT as DewDiligence 08/03/17 09:02:53 AM #517   0 Very interesting link osaffer 08/03/17 02:35:01 AM #516   0 These results are awesome ... osaffer 08/03/17 02:33:37 AM #515   0 2Q17 CC slides: DewDiligence 07/31/17 11:03:35 AM #514   0 2Q17 results: DewDiligence 07/31/17 11:01:35 AM #513   0 Small phase-2 shows adding statins to Ocaliva neutralizes DewDiligence 07/31/17 10:59:55 AM #512   0 It's to the point now I can't defend Spike5 05/30/17 11:40:24 AM #511   0 You're preaching to the choir vis-á-vis Ocaliva. I'm DewDiligence 03/13/17 12:02:37 PM #510   0 Dont forget, that OCALIVA has received approbation from osaffer 03/13/17 11:46:45 AM #509   0 Not a big deal, IMO: #msg-129405710. DewDiligence 03/13/17 09:37:58 AM #508   0 FXR agonist Cancer ? This is not good osaffer 03/13/17 08:43:12 AM #507   0 The CC slides have only the design outline DewDiligence 02/23/17 11:23:57 AM #506   0 ICPT 4Q16 CC slides: DewDiligence 02/23/17 11:23:06 AM #505   0 ICPT -8% on 4Q16 results: #msg-128940872. DewDiligence 02/23/17 11:13:31 AM #504   0 Just listen and watch the slides ... osaffer 02/17/17 07:39:47 AM #503   0 I am not based in France. osaffer 02/17/17 07:39:11 AM #502   0 Analyst Activity – Wedbush Reiterates Outperform on Intercept trendmkr 02/16/17 03:06:04 PM #501   0 Intervention? More like nonsensical biased vomiting. Hanibal 02/16/17 10:45:40 AM #500   0 Wow, you can only say that in response osaffer 02/16/17 08:33:35 AM #499   0 Blah Blah Blah Go back to your hole froggy Hanibal 02/15/17 11:16:20 AM Post Subject

© 2018 InvestorsHub.com, Inc.